China health system reform needs more accountability

Press release from PLOS Medicine

2012-11-07

(Press-News.org) In this week's PLOS Medicine, David Hipgrave from the University of Melbourne, Australia and colleagues discuss health system reform in China and argue that parallel reforms in governance, financing, and accountability are also needed to ensure health equity.

### Funding: No specific funding was received to write this article.

Competing Interests: The authors have declared that no competing interests exist. The opinions expressed in this paper reflect the perspectives of the authors alone, and may not be inferred to represent the position of their parent institutions.

Citation: Hipgrave D, Guo S, Mu Y, Guo Y, Yan F, et al. (2012) Chinese-Style Decentralization and Health System Reform. PLoS Med 9(11): e1001337. doi:10.1371/journal.pmed.1001337

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER (THIS LINK WILL BECOME LIVE WHEN THE EMBARGO LIFTS):

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001337

CONTACT:

David Hipgrave
Nossal Institute for Global Health
University of Melbourne
Melbourne, Australia
dhipgrave@gmail.com END

ELSE PRESS RELEASES FROM THIS DATE:

Small change in defibrillator therapy leads to huge benefits for heart patients

2012-11-07

A new study shows that defibrillators – devices designed to detect and correct dangerous heart rhythms – can help people with heart disease live longer, and with a much better quality of life, than they do now. A small, very simple change in the way physicians set or programmed the device led to a dramatic 80 to 90 percent reduction in inappropriate therapies – potentially painful and anxiety-provoking shocks delivered for rhythms that aren't dangerous or life threatening. And, to the authors' surprise, the new programming also significantly increased survival, lowering ...

NIH study finds leisure-time physical activity extends life expectancy as much as 4.5 years

2012-11-07

Leisure-time physical activity is associated with longer life expectancy, even at relatively low levels of activity and regardless of body weight, according to a study by a team of researchers led by the National Cancer Institute (NCI), part of the National Institutes of Health. The study, which found that people who engaged in leisure-time physical activity had life expectancy gains of as much as 4.5 years, appeared Nov. 6, 2012, in PLOS Medicine. In order to determine the number of years of life gained from leisure-time physical activity in adulthood, which translates ...

2 years out, patients receiving stem cell therapy show sustained heart function improvement

2012-11-07

LOS ANGELES – Marked sustained improvement in all patients with zero adverse effects. For a phase I clinical trial, these results are the Holy Grail. Yet researchers from the University of Louisville and Brigham and Women's Hospital today reported just such almost-never-attained data. In a Late-Breaking Clinical Trial session at the American Heart Association Scientific Sessions 2012 meeting, Roberto Bolli, M.D., of the University of Louisville and Piero Anversa, M.D., of Brigham and Women's Hospital, Boston, presented data from their groundbreaking research in the ...

Discovery may help nerve regeneration in spinal injury

2012-11-07

Scientists at the Universities of Liverpool and Glasgow have uncovered a possible new method of enhancing nerve repair in the treatment of spinal cord injuries. It is known that scar tissue, which forms following spinal cord injury, creates an impenetrable barrier to nerve regeneration, leading to the irreversible paralysis associated with spinal injuries. Scientists at Liverpool and Glasgow have discovered that long-chain sugars, called heparan sulfates, play a significant role in the process of scar formation in cell models in the laboratory. Research findings have ...

Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments

2012-11-07

Scientists in the United States have tested all possible pairings of the 100 cancer drugs approved for use in patients in order to discover whether there are any combinations not tried previously that are effective in certain cancers. Dr Susan Holbeck (PhD), a biologist in the Division of Cancer Treatment and Diagnosis at the National Cancer Institute (USA) will tell the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland, today (Wednesday) that she and her colleagues have completed testing the 100 drugs, with 300,000 experiments ...

New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial

2012-11-07

A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland, today (Wednesday). [2] A patient with advanced malignant melanoma has shown signs of tumour shrinkage and has been receiving treatment for more than 30 weeks without any serious adverse side-effects. Other patients with advanced non-small cell lung cancer (NSCLC), mesothelioma, ...

Mothers’ age at menopause may predict daughters’ ovarian reserve

2012-11-07

A mother's age at menopause may predict her daughter's fertility in terms of the numbers of eggs remaining in her ovaries, according to the new research published online in Europe's leading reproductive medicine journal Human Reproduction [1] today. By assessing ovarian reserve with two accepted methods – levels of anti-Müllerian hormone (AMH) and antral follicle count (AFC) – in daughters and comparing it with the age of menopause in their mothers, researchers found that both AMH and AFC declined faster in women whose mothers had an early menopause compared to women ...

Stem cell therapy using patient's own cells after heart attack does not enhance cardiac recovery

2012-11-07

MINNEAPOLIS, MN – November 6, 2012 – Administering autologous stem cells obtained from bone marrow either 3 or 7 days following a heart attack did not improve heart function six months later, reports a new clinical trial supported by the National Institutes of Health. The results of this trial, called TIME (Transplantation In Myocardial Infarction Evaluation), were presented by Jay Traverse, MD of the Minneapolis Heart Institute Foundation Tuesday, Nov. 6, at the 2012 Scientific Sessions of the American Heart Association in Los Angeles. The results of this trial mirror ...

Physical activity and gain in life expectancy -- quantified

2012-11-07

Boston, MA—We all know that exercise is good for you, but how good? While previous studies have shown the link between physical activity and a lower risk of premature mortality, the number of years of life expectancy gained among persons with different activity levels has been unclear—until now. In a new study from Brigham and Women's Hospital (BWH), in collaboration with the National Cancer Institute, researchers have quantified how many years of life are gained by being physically active at different levels, among all individuals as well as among various groups with ...

Saber-toothed cats and bear dogs: How they made cohabitation work

2012-11-07

ANN ARBOR—The fossilized fangs of saber-toothed cats hold clues to how the extinct mammals shared space and food with other large predators 9 million years ago. Led by the University of Michigan and the Museo Nacional de Ciencias Naturales in Madrid, a team of paleontologists has analyzed the tooth enamel of two species of saber-toothed cats and a bear dog unearthed in geological pits near Madrid. Bear dogs, also extinct, had dog-like teeth and a bear-like body and gait. The researchers found that the cat species—a leopard-sized Promegantereon ogygia and a much larger, ...

LAST 30 PRESS RELEASES:

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer